ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats (2017)
Maranhão, Raul Cavalcante ; Marques, Alyne França; Guido, Maria Carolina; Tavares, Elaine Rufo; Bispo, Deborah Lima; Melo, Marcelo Dantas Tavares de; Salemi, Vera Maria Cury
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: NANOPARTÍCULAS, RATOS, METOTREXATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2017
APA
Maranhão, R. C., Marques, A. F., Guido, M. C., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, & Salemi, V. M. C. (2017). Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 nov. 10 ]
Vancouver
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects (2017)
Maranhão, Raul Cavalcante ; Oliveira, Wilson Camargo; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues; Silva, Bruna Miranda; Kalil Filho, Roberto
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: SEDENTARISMO, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.704. Acesso em: 10 nov. 2024. , 2017
APA
Maranhão, R. C., Oliveira, W. C., Tavoni, T. M., Freitas, F. R., Silva, B. M., & Kalil Filho, R. (2017). Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.704
NLM
Maranhão RC, Oliveira WC, Tavoni TM, Freitas FR, Silva BM, Kalil Filho R. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects [Internet]. Atherosclerosis. 2017 ; 263 e216.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.704
Vancouver
Maranhão RC, Oliveira WC, Tavoni TM, Freitas FR, Silva BM, Kalil Filho R. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects [Internet]. Atherosclerosis. 2017 ; 263 e216.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.704
Trabalho de evento-resumo periodico
Next generation sequencing in the diagnosis of familial hypercholesterolemia (2017)
Borges, Jessica Bassabi; Bastos, Gisele Medeiros; Afonso, Thais Kristini Almendros; Rodrigues, Elisângela da Silva; Thurow, Helena Strelow; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Sousa, Amanda Guerra de Moraes Rego; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jessica Bassabi et al. Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2017
APA
Borges, J. B., Bastos, G. M., Afonso, T. K. A., Rodrigues, E. da S., Thurow, H. S., Faludi, A. A., et al. (2017). Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Borges JB, Bastos GM, Afonso TKA, Rodrigues E da S, Thurow HS, Faludi AA, Gonçalves RM, Sousa AG de MR, Hirata RDC, Hirata MH. Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. 2017 ; 263 e282 res. PO558.[citado 2024 nov. 10 ]
Vancouver
Borges JB, Bastos GM, Afonso TKA, Rodrigues E da S, Thurow HS, Faludi AA, Gonçalves RM, Sousa AG de MR, Hirata RDC, Hirata MH. Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. 2017 ; 263 e282 res. PO558.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels (2017)
Martine, Ana Elisa Marabini; Carvalho, Priscila O; Curiati, Milena N. C; Miranda, Bruna O; Freitas, Fatima R; Kalil Filho, Roberto; Barretto, Antonio Carlos Pereira; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: INSUFICIÊNCIA CARDÍACA, LIPOPROTEÍNAS HDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINE, Ana Elisa Marabini et al. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.243. Acesso em: 10 nov. 2024. , 2017
APA
Martine, A. E. M., Carvalho, P. O., Curiati, M. N. C., Miranda, B. O., Freitas, F. R., Kalil Filho, R., et al. (2017). Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.243
NLM
Martine AEM, Carvalho PO, Curiati MNC, Miranda BO, Freitas FR, Kalil Filho R, Barretto ACP, Maranhão RC. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels [Internet]. Atherosclerosis. 2017 ; 263 e073.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.243
Vancouver
Martine AEM, Carvalho PO, Curiati MNC, Miranda BO, Freitas FR, Kalil Filho R, Barretto ACP, Maranhão RC. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels [Internet]. Atherosclerosis. 2017 ; 263 e073.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.243
Trabalho de evento-resumo periodico
Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus (2017)
Maranhão, Raul Cavalcante ; Tavoni, Thauany Martins; Laverdy Neto, Oscar Giese; Sprandel, Marília da Costa Oliveira; Kalil Filho, Roberto; Hueb, Whady Armindo
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.706. Acesso em: 10 nov. 2024. , 2017
APA
Maranhão, R. C., Tavoni, T. M., Laverdy Neto, O. G., Sprandel, M. da C. O., Kalil Filho, R., & Hueb, W. A. (2017). Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.706
NLM
Maranhão RC, Tavoni TM, Laverdy Neto OG, Sprandel M da CO, Kalil Filho R, Hueb WA. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus [Internet]. Atherosclerosis. 2017 ; 263 e217.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.706
Vancouver
Maranhão RC, Tavoni TM, Laverdy Neto OG, Sprandel M da CO, Kalil Filho R, Hueb WA. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus [Internet]. Atherosclerosis. 2017 ; 263 e217.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.706
Trabalho de evento-resumo periodico
Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats (2017)
Maranhão, Raul Cavalcante ; Guido, Maria Carolina; Marques, Alyne França; Tavares, Elaine Rufo; Bispo, Deborah Lima; Melo, Marcelo Dantas Tavares de; Lima, Aline Derísio; Nicolau, José Carlos; Salemi, Vera Maria; Kalil Filho, Roberto
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: INFARTO DO MIOCÁRDIO, NANOPARTÍCULAS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.405. Acesso em: 10 nov. 2024. , 2017
APA
Maranhão, R. C., Guido, M. C., Marques, A. F., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, et al. (2017). Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.405
NLM
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405
Vancouver
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405
Trabalho de evento-resumo periodico
Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins (2014)
Hirata, Mario Hiroyuki ; Cavichioli, Débora; Germano, Juliana de Freitas; Braga, Aécio Assunção; Cerda, Alvaro; Fajardo, Cristina Moreno ; Sampaio, M. F; Santos, E. B; Menuso, L; Sousa, A. G. M. R; Hirata, Rosario Dominguez Crespo
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2014
APA
Hirata, M. H., Cavichioli, D., Germano, J. de F., Braga, A. A., Cerda, A., Fajardo, C. M., et al. (2014). Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH, Cavichioli D, Germano J de F, Braga AA, Cerda A, Fajardo CM, Sampaio MF, Santos EB, Menuso L, Sousa AGMR, Hirata RDC. Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. 2014 ; 235( 2): e41 res. EAS-0819.[citado 2024 nov. 10 ]
Vancouver
Hirata MH, Cavichioli D, Germano J de F, Braga AA, Cerda A, Fajardo CM, Sampaio MF, Santos EB, Menuso L, Sousa AGMR, Hirata RDC. Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. 2014 ; 235( 2): e41 res. EAS-0819.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Pleiotropic effects of plant sterols compared with ezetimibe on atherosclerosis biomarkers in type 2 diabetic patients treated with statins (2014)
Bertolami, Adriana; Botelho, Patrícia Borges; Macedo, Luciene Fagundes Lauer; Abdalla, Dulcinéia Saes Parra ; Faludi, André Arpad; Galasso, Melissa; Castro, Inar Alves de
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: ARTERIOSCLEROSE, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTOLAMI, Adriana et al. Pleiotropic effects of plant sterols compared with ezetimibe on atherosclerosis biomarkers in type 2 diabetic patients treated with statins. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2014
APA
Bertolami, A., Botelho, P. B., Macedo, L. F. L., Abdalla, D. S. P., Faludi, A. A., Galasso, M., & Castro, I. A. de. (2014). Pleiotropic effects of plant sterols compared with ezetimibe on atherosclerosis biomarkers in type 2 diabetic patients treated with statins. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Bertolami A, Botelho PB, Macedo LFL, Abdalla DSP, Faludi AA, Galasso M, Castro IA de. Pleiotropic effects of plant sterols compared with ezetimibe on atherosclerosis biomarkers in type 2 diabetic patients treated with statins. Atherosclerosis. 2014 ; 235( 2): e74 res. EAS-0028.[citado 2024 nov. 10 ]
Vancouver
Bertolami A, Botelho PB, Macedo LFL, Abdalla DSP, Faludi AA, Galasso M, Castro IA de. Pleiotropic effects of plant sterols compared with ezetimibe on atherosclerosis biomarkers in type 2 diabetic patients treated with statins. Atherosclerosis. 2014 ; 235( 2): e74 res. EAS-0028.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol (2014)
Cerda, Alvaro; Rodrigues, Alice Cristina ; Alves, Camila; Genvigir, Fabiana Dalla Vecchia; Fajardo, Cristina Moreno ; Dórea, Egidio Lima; Gusukuma, Maria Cecília; Pinto, Gelson de Almeida; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: ICB, FCF, HU
Subjects: COLESTEROL, MONÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. Clare: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2014
APA
Cerda, A., Rodrigues, A. C., Alves, C., Genvigir, F. D. V., Fajardo, C. M., Dórea, E. L., et al. (2014). Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. Clare: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dórea EL, Gusukuma MC, Pinto G de A, Hirata MH, Hirata RDC. Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. 2014 ; 235( 2): e255 res. EAS-0490.[citado 2024 nov. 10 ]
Vancouver
Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dórea EL, Gusukuma MC, Pinto G de A, Hirata MH, Hirata RDC. Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. 2014 ; 235( 2): e255 res. EAS-0490.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease (2014)
Sprandel, Marilia da Costa Oliveira; Hueb, Whady Armindo; Segre, Alexandre; Laverdy Neto, Oscar Giese; Leite Junior, Antonio Carlos de Arruda; Freitas, Fátima Rodrigues; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS LDL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPRANDEL, Marilia da Costa Oliveira et al. In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2014
APA
Sprandel, M. da C. O., Hueb, W. A., Segre, A., Laverdy Neto, O. G., Leite Junior, A. C. de A., Freitas, F. R., et al. (2014). In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sprandel M da CO, Hueb WA, Segre A, Laverdy Neto OG, Leite Junior AC de A, Freitas FR, Kalil Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. 2014 ; 235( 2): e102-e103 res. EAS-0801.[citado 2024 nov. 10 ]
Vancouver
Sprandel M da CO, Hueb WA, Segre A, Laverdy Neto OG, Leite Junior AC de A, Freitas FR, Kalil Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. 2014 ; 235( 2): e102-e103 res. EAS-0801.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease (2014)
Sprandel, M. C. O.; Hueb, W. A.; Segre, A. C.; Laverdy, O. G.; Leite-Júnior, A. C.; Freitas, F. R.; Kalil-Filho, R.; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FM, FCF
Subjects: COLESTEROL (METABOLISMO;SÍNTESE), PLASMA, DOENÇAS CARDIOVASCULARES, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPRANDEL, M. C. O. et al. In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science/article/pii/S0021915014005115. Acesso em: 10 nov. 2024. , 2014
APA
Sprandel, M. C. O., Hueb, W. A., Segre, A. C., Laverdy, O. G., Leite-Júnior, A. C., Freitas, F. R., et al. (2014). In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science/article/pii/S0021915014005115
NLM
Sprandel MCO, Hueb WA, Segre AC, Laverdy OG, Leite-Júnior AC, Freitas FR, Kalil-Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease [Internet]. Atherosclerosis. 2014 ; 235( 2): e101-e102.[citado 2024 nov. 10 ] Available from: http://www.sciencedirect.com/science/article/pii/S0021915014005115
Vancouver
Sprandel MCO, Hueb WA, Segre AC, Laverdy OG, Leite-Júnior AC, Freitas FR, Kalil-Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease [Internet]. Atherosclerosis. 2014 ; 235( 2): e101-e102.[citado 2024 nov. 10 ] Available from: http://www.sciencedirect.com/science/article/pii/S0021915014005115
Trabalho de evento-resumo
Novel arylidene-thiazolidinediones with no adipogenic effects (2013)
Silva, Jacqueline Cavalcante; Saito, Cristiane Akemi Iamamoto; César, Fernanda Andrade de; Rudnicki, Martina; Galdino, Sergio Luiz; Pitta, Ivan da Rocha; Lima, M. C; Boss, M; Knap, T; Kemmerer, M; Brüne, Bernhard; Namgaladze, Dmitry; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: INSULINA, HIPERGLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. Novel arylidene-thiazolidinediones with no adipogenic effects. 2013, Anais.. Gothenburg: European Atherosclerosis Society, 2013. . Acesso em: 10 nov. 2024.
APA
Silva, J. C., Saito, C. A. I., César, F. A. de, Rudnicki, M., Galdino, S. L., Pitta, I. da R., et al. (2013). Novel arylidene-thiazolidinediones with no adipogenic effects. In Abstracts. Gothenburg: European Atherosclerosis Society.
NLM
Silva JC, Saito CAI, César FA de, Rudnicki M, Galdino SL, Pitta I da R, Lima MC, Boss M, Knap T, Kemmerer M, Brüne B, Namgaladze D, Abdalla DSP. Novel arylidene-thiazolidinediones with no adipogenic effects. Abstracts. 2013 ;[citado 2024 nov. 10 ]
Vancouver
Silva JC, Saito CAI, César FA de, Rudnicki M, Galdino SL, Pitta I da R, Lima MC, Boss M, Knap T, Kemmerer M, Brüne B, Namgaladze D, Abdalla DSP. Novel arylidene-thiazolidinediones with no adipogenic effects. Abstracts. 2013 ;[citado 2024 nov. 10 ]
Trabalho de evento-resumo
Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients (2013)
Cerda, Alvaro; Fajardo, Cristina Moreno ; Guimaraes, E. S; Dórea, Egidio Lima; Gosukuma, M. C; Pinto, Gelba Almeida; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. 2013, Anais.. Gothenburg: European Atherosclerosis Society, 2013. . Acesso em: 10 nov. 2024.
APA
Cerda, A., Fajardo, C. M., Guimaraes, E. S., Dórea, E. L., Gosukuma, M. C., Pinto, G. A., et al. (2013). Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. In Abstracts. Gothenburg: European Atherosclerosis Society.
NLM
Cerda A, Fajardo CM, Guimaraes ES, Dórea EL, Gosukuma MC, Pinto GA, Hirata MH, Hirata RDC. Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. Abstracts. 2013 ;[citado 2024 nov. 10 ]
Vancouver
Cerda A, Fajardo CM, Guimaraes ES, Dórea EL, Gosukuma MC, Pinto GA, Hirata MH, Hirata RDC. Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. Abstracts. 2013 ;[citado 2024 nov. 10 ]
Trabalho de evento-resumo
Influence of the molecular composition on the LDL and HDL funcional characteristics in patients with the metabolic syndrome (2012)
Casella Filho, Antonio; Trombetta, Ivani Credidio; Leite Junior, Antonio Carlos de Arruda; Sprandel, M. O; Casella, L. B; Segre, A; Denardi, Celise A; Dourado, P. M; Maranhão, Raul Cavalcante ; Chagas, A. C. P
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Assunto: SÍNDROME X METABÓLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASELLA FILHO, Antonio et al. Influence of the molecular composition on the LDL and HDL funcional characteristics in patients with the metabolic syndrome. 2012, Anais.. Gothenburg: European Atherosclerosis Society, 2012. . Acesso em: 10 nov. 2024.
APA
Casella Filho, A., Trombetta, I. C., Leite Junior, A. C. de A., Sprandel, M. O., Casella, L. B., Segre, A., et al. (2012). Influence of the molecular composition on the LDL and HDL funcional characteristics in patients with the metabolic syndrome. In Abstracts. Gothenburg: European Atherosclerosis Society.
NLM
Casella Filho A, Trombetta IC, Leite Junior AC de A, Sprandel MO, Casella LB, Segre A, Denardi CA, Dourado PM, Maranhão RC, Chagas ACP. Influence of the molecular composition on the LDL and HDL funcional characteristics in patients with the metabolic syndrome. Abstracts. 2012 ;[citado 2024 nov. 10 ]
Vancouver
Casella Filho A, Trombetta IC, Leite Junior AC de A, Sprandel MO, Casella LB, Segre A, Denardi CA, Dourado PM, Maranhão RC, Chagas ACP. Influence of the molecular composition on the LDL and HDL funcional characteristics in patients with the metabolic syndrome. Abstracts. 2012 ;[citado 2024 nov. 10 ]
Trabalho de evento-resumo
High sensitivity cardiac Troponin I levels in diabetic patients with and without angiographic obstructive coronary artery disease (2012)
Segre, Alexandre; Casella Filho, Antonio; Sprandel,M; Favarato, Desiderio; Strunz, C; Roggério, Alessandra; Rezende, P; Garzillo, R. C; Maranhão, Raul Cavalcante ; Hueb, Whady Armindo
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: DOENÇAS CARDIOVASCULARES, TROPONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGRE, Alexandre et al. High sensitivity cardiac Troponin I levels in diabetic patients with and without angiographic obstructive coronary artery disease. 2012, Anais.. Gothenburg: European Atherosclerosis Society, 2012. . Acesso em: 10 nov. 2024.
APA
Segre, A., Casella Filho, A., Sprandel, M., Favarato, D., Strunz, C., Roggério, A., et al. (2012). High sensitivity cardiac Troponin I levels in diabetic patients with and without angiographic obstructive coronary artery disease. In Abstracts. Gothenburg: European Atherosclerosis Society.
NLM
Segre A, Casella Filho A, Sprandel M, Favarato D, Strunz C, Roggério A, Rezende P, Garzillo RC, Maranhão RC, Hueb WA. High sensitivity cardiac Troponin I levels in diabetic patients with and without angiographic obstructive coronary artery disease. Abstracts. 2012 ;[citado 2024 nov. 10 ]
Vancouver
Segre A, Casella Filho A, Sprandel M, Favarato D, Strunz C, Roggério A, Rezende P, Garzillo RC, Maranhão RC, Hueb WA. High sensitivity cardiac Troponin I levels in diabetic patients with and without angiographic obstructive coronary artery disease. Abstracts. 2012 ;[citado 2024 nov. 10 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em